Skip to main content
Journal cover image

Precessation treatment with nicotine skin patch facilitates smoking cessation.

Publication ,  Journal Article
Rose, JE; Behm, FM; Westman, EC; Kukovich, P
Published in: Nicotine Tob Res
February 2006

Nicotine replacement therapy (NRT) is a well-established treatment to aid smoking cessation, and current products recommend using NRT only after quitting smoking. However, theoretical arguments and previous data support the hypothesis that precessation use of NRT might be useful in reducing dependence on inhaled nicotine and serve as a helpful prelude to smoking cessation. The present study explored the use of NRT for 2 weeks before a target quit-smoking date, during which subjects continued to smoke ad libitum. Three experimental conditions varied the nicotine delivery of the cigarettes smoked during these 2 weeks so that we could examine the effects of concurrent nicotine administration on compensatory smoking of low tar and nicotine cigarettes. Subjects smoked (a) their usual brands of cigarettes, (b) conventional low tar and nicotine cigarettes, or (c) denicotinized cigarettes. After the quit date, subjects received pharmacotherapy consisting of various doses of NRT (0, 21, or 42 mg/24-hr) in combination with the nicotinic antagonist mecamylamine (10 mg/day). Results showed that precessation nicotine patch treatment was associated with a significantly higher rate of continuous smoking abstinence at 4 weeks, regardless of cigarette condition. Ad libitum smoking before the target quit date was modulated by nicotine patch treatment, and compensatory increases in smoking low tar and nicotine cigarettes were prevented by concurrent use of nicotine patches. These results suggest that use of NRT before a target quit-smoking date deserves further evaluation as a possible smoking cessation treatment. Moreover, while nicotine patches were well tolerated when subjects smoked nicotine-containing cigarettes, the use of nicotine skin patches with reduced-nicotine cigarettes potentially offers the advantage of increased efficacy without introducing concern about toxic effects of excessive nicotine intake.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nicotine Tob Res

DOI

ISSN

1462-2203

Publication Date

February 2006

Volume

8

Issue

1

Start / End Page

89 / 101

Location

England

Related Subject Headings

  • Time Factors
  • Smoking Prevention
  • Smoking Cessation
  • Saliva
  • Public Health
  • Nicotinic Antagonists
  • Nicotine
  • Mecamylamine
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rose, J. E., Behm, F. M., Westman, E. C., & Kukovich, P. (2006). Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res, 8(1), 89–101. https://doi.org/10.1080/14622200500431866
Rose, Jed E., Frederique M. Behm, Eric C. Westman, and Prity Kukovich. “Precessation treatment with nicotine skin patch facilitates smoking cessation.Nicotine Tob Res 8, no. 1 (February 2006): 89–101. https://doi.org/10.1080/14622200500431866.
Rose JE, Behm FM, Westman EC, Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res. 2006 Feb;8(1):89–101.
Rose, Jed E., et al. “Precessation treatment with nicotine skin patch facilitates smoking cessation.Nicotine Tob Res, vol. 8, no. 1, Feb. 2006, pp. 89–101. Pubmed, doi:10.1080/14622200500431866.
Rose JE, Behm FM, Westman EC, Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res. 2006 Feb;8(1):89–101.
Journal cover image

Published In

Nicotine Tob Res

DOI

ISSN

1462-2203

Publication Date

February 2006

Volume

8

Issue

1

Start / End Page

89 / 101

Location

England

Related Subject Headings

  • Time Factors
  • Smoking Prevention
  • Smoking Cessation
  • Saliva
  • Public Health
  • Nicotinic Antagonists
  • Nicotine
  • Mecamylamine
  • Male
  • Humans